HEADER TRANSFERASE/TRANSFERASE INHIBITOR 27-JUN-16 5KMI TITLE TRKA JM-KINASE WITH 1-(9{H}-FLUOREN-9-YL)-3-(2-METHYL-4-PHENYL- TITLE 2 PYRIMIDIN-5-YL)UREA COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN WITH JUXTAMEMBRANE REGION, UNP RESIDUES COMPND 5 376-698; COMPND 6 SYNONYM: NEUROTROPHIC TYROSINE KINASE RECEPTOR TYPE 1,TRK1- COMPND 7 TRANSFORMING TYROSINE KINASE PROTEIN,TROPOMYOSIN-RELATED KINASE A, COMPND 8 TYROSINE KINASE RECEPTOR,TYROSINE KINASE RECEPTOR A,TRK-A,GP140TRK, COMPND 9 P140-TRKA; COMPND 10 EC: 2.7.10.1; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NTRK1, MTC, TRK, TRKA; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE, JUXTAMEMBRANE, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.P.SU REVDAT 4 06-MAR-24 5KMI 1 REMARK REVDAT 3 01-FEB-17 5KMI 1 JRNL REVDAT 2 18-JAN-17 5KMI 1 JRNL REVDAT 1 28-DEC-16 5KMI 0 JRNL AUTH H.P.SU,K.RICKERT,C.BURLEIN,K.NARAYAN,M.BUKHTIYAROVA, JRNL AUTH 2 D.M.HURZY,C.A.STUMP,X.ZHANG,J.REID,A.KRASOWSKA-ZOLADEK, JRNL AUTH 3 S.TUMMALA,J.M.SHIPMAN,M.KORNIENKO,P.A.LEMAIRE,D.KROSKY, JRNL AUTH 4 A.HELLER,A.ACHAB,C.CHAMBERLIN,P.SARADJIAN,B.SAUVAGNAT, JRNL AUTH 5 X.YANG,M.R.ZIEBELL,E.NICKBARG,J.M.SANDERS,M.T.BILODEAU, JRNL AUTH 6 S.S.CARROLL,K.J.LUMB,S.M.SOISSON,D.A.HENZE,A.J.COOKE JRNL TITL STRUCTURAL CHARACTERIZATION OF NONACTIVE SITE, JRNL TITL 2 TRKA-SELECTIVE KINASE INHIBITORS. JRNL REF PROC. NATL. ACAD. SCI. V. 114 E297 2017 JRNL REF 2 U.S.A. JRNL REFN ESSN 1091-6490 JRNL PMID 28039433 JRNL DOI 10.1073/PNAS.1611577114 REMARK 2 REMARK 2 RESOLUTION. 1.87 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.87 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.09 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 29752 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 1507 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 15 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.87 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.94 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.98 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2876 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2369 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2732 REMARK 3 BIN R VALUE (WORKING SET) : 0.2357 REMARK 3 BIN FREE R VALUE : 0.2605 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.01 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 144 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2373 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 108 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 32.68 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.19 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.35190 REMARK 3 B22 (A**2) : -1.35190 REMARK 3 B33 (A**2) : 2.70370 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.250 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.139 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.133 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.138 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.134 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.927 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2465 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3340 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 840 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 51 ; 8.000 ; HARMONIC REMARK 3 GENERAL PLANES : 393 ; 8.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2465 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 299 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2862 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.00 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.26 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.10 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5KMI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-JUN-16. REMARK 100 THE DEPOSITION ID IS D_1000222459. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-MAR-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.16 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29938 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.868 REMARK 200 RESOLUTION RANGE LOW (A) : 45.090 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 9.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05200 REMARK 200 FOR THE DATA SET : 24.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.87 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 10.20 REMARK 200 R MERGE FOR SHELL (I) : 0.50400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: BUSTER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.43 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50MM MES PH 6.5, 150 MM NACL, 5MM REMARK 280 TCEP, 0.1% BETA-OCTYLGLUCOSIDE, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 1 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -Y,-X,-Z+2/3 REMARK 290 5555 -X+Y,Y,-Z+1/3 REMARK 290 6555 X,X-Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.73033 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 151.46067 REMARK 290 SMTRY1 4 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 151.46067 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 75.73033 REMARK 290 SMTRY1 6 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14300 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 474 REMARK 465 SER A 475 REMARK 465 LEU A 476 REMARK 465 SER A 477 REMARK 465 PRO A 478 REMARK 465 THR A 479 REMARK 465 GLU A 480 REMARK 465 GLY A 481 REMARK 465 LYS A 482 REMARK 465 GLY A 483 REMARK 465 SER A 484 REMARK 465 GLY A 485 REMARK 465 TYR A 496 REMARK 465 PHE A 497 REMARK 465 SER A 498 REMARK 465 ASP A 499 REMARK 465 ALA A 500 REMARK 465 GLU A 548 REMARK 465 ALA A 549 REMARK 465 SER A 550 REMARK 465 LEU A 611 REMARK 465 ALA A 612 REMARK 465 GLY A 613 REMARK 465 HIS A 797 REMARK 465 HIS A 798 REMARK 465 HIS A 799 REMARK 465 HIS A 800 REMARK 465 HIS A 801 REMARK 465 HIS A 802 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 535 CG CD OE1 OE2 REMARK 470 GLN A 536 CG CD OE1 NE2 REMARK 470 GLU A 551 CG CD OE1 OE2 REMARK 470 GLN A 555 CG CD OE1 NE2 REMARK 470 GLN A 570 CG CD OE1 NE2 REMARK 470 LYS A 609 CG CD CE NZ REMARK 470 LEU A 610 CG CD1 CD2 REMARK 470 ARG A 686 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 536 -45.45 -137.40 REMARK 500 ASP A 537 -47.47 65.92 REMARK 500 ARG A 649 -9.09 75.77 REMARK 500 TYR A 676 52.06 -117.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6UE A 901 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5KMJ RELATED DB: PDB REMARK 900 RELATED ID: 5KMK RELATED DB: PDB REMARK 900 RELATED ID: 5KML RELATED DB: PDB REMARK 900 RELATED ID: 5KMM RELATED DB: PDB REMARK 900 RELATED ID: 5KMN RELATED DB: PDB REMARK 900 RELATED ID: 5KMO RELATED DB: PDB DBREF 5KMI A 474 796 UNP P04629 NTRK1_HUMAN 376 698 SEQADV 5KMI HIS A 797 UNP P04629 EXPRESSION TAG SEQADV 5KMI HIS A 798 UNP P04629 EXPRESSION TAG SEQADV 5KMI HIS A 799 UNP P04629 EXPRESSION TAG SEQADV 5KMI HIS A 800 UNP P04629 EXPRESSION TAG SEQADV 5KMI HIS A 801 UNP P04629 EXPRESSION TAG SEQADV 5KMI HIS A 802 UNP P04629 EXPRESSION TAG SEQRES 1 A 329 SER SER LEU SER PRO THR GLU GLY LYS GLY SER GLY LEU SEQRES 2 A 329 GLN GLY HIS ILE ILE GLU ASN PRO GLN TYR PHE SER ASP SEQRES 3 A 329 ALA CYS VAL HIS HIS ILE LYS ARG ARG ASP ILE VAL LEU SEQRES 4 A 329 LYS TRP GLU LEU GLY GLU GLY ALA PHE GLY LYS VAL PHE SEQRES 5 A 329 LEU ALA GLU CYS HIS ASN LEU LEU PRO GLU GLN ASP LYS SEQRES 6 A 329 MET LEU VAL ALA VAL LYS ALA LEU LYS GLU ALA SER GLU SEQRES 7 A 329 SER ALA ARG GLN ASP PHE GLN ARG GLU ALA GLU LEU LEU SEQRES 8 A 329 THR MET LEU GLN HIS GLN HIS ILE VAL ARG PHE PHE GLY SEQRES 9 A 329 VAL CYS THR GLU GLY ARG PRO LEU LEU MET VAL PHE GLU SEQRES 10 A 329 TYR MET ARG HIS GLY ASP LEU ASN ARG PHE LEU ARG SER SEQRES 11 A 329 HIS GLY PRO ASP ALA LYS LEU LEU ALA GLY GLY GLU ASP SEQRES 12 A 329 VAL ALA PRO GLY PRO LEU GLY LEU GLY GLN LEU LEU ALA SEQRES 13 A 329 VAL ALA SER GLN VAL ALA ALA GLY MET VAL TYR LEU ALA SEQRES 14 A 329 GLY LEU HIS PHE VAL HIS ARG ASP LEU ALA THR ARG ASN SEQRES 15 A 329 CYS LEU VAL GLY GLN GLY LEU VAL VAL LYS ILE GLY ASP SEQRES 16 A 329 PHE GLY MET SER ARG ASP ILE TYR SER THR ASP TYR TYR SEQRES 17 A 329 ARG VAL GLY GLY ARG THR MET LEU PRO ILE ARG TRP MET SEQRES 18 A 329 PRO PRO GLU SER ILE LEU TYR ARG LYS PHE THR THR GLU SEQRES 19 A 329 SER ASP VAL TRP SER PHE GLY VAL VAL LEU TRP GLU ILE SEQRES 20 A 329 PHE THR TYR GLY LYS GLN PRO TRP TYR GLN LEU SER ASN SEQRES 21 A 329 THR GLU ALA ILE ASP CYS ILE THR GLN GLY ARG GLU LEU SEQRES 22 A 329 GLU ARG PRO ARG ALA CYS PRO PRO GLU VAL TYR ALA ILE SEQRES 23 A 329 MET ARG GLY CYS TRP GLN ARG GLU PRO GLN GLN ARG HIS SEQRES 24 A 329 SER ILE LYS ASP VAL HIS ALA ARG LEU GLN ALA LEU ALA SEQRES 25 A 329 GLN ALA PRO PRO VAL TYR LEU ASP VAL LEU GLY HIS HIS SEQRES 26 A 329 HIS HIS HIS HIS HET 6UE A 901 30 HETNAM 6UE 1-(9~{H}-FLUOREN-9-YL)-3-(2-METHYL-4-PHENYL-PYRIMIDIN- HETNAM 2 6UE 5-YL)UREA FORMUL 2 6UE C25 H20 N4 O FORMUL 3 HOH *108(H2 O) HELIX 1 AA1 HIS A 489 ASN A 493 5 5 HELIX 2 AA2 LYS A 506 ARG A 508 5 3 HELIX 3 AA3 SER A 552 LEU A 567 1 16 HELIX 4 AA4 ASP A 596 HIS A 604 1 9 HELIX 5 AA5 GLY A 623 LEU A 644 1 22 HELIX 6 AA6 ALA A 652 ARG A 654 5 3 HELIX 7 AA7 MET A 671 TYR A 676 1 6 HELIX 8 AA8 SER A 677 TYR A 680 5 4 HELIX 9 AA9 PRO A 690 MET A 694 5 5 HELIX 10 AB1 PRO A 695 ARG A 702 1 8 HELIX 11 AB2 THR A 705 THR A 722 1 18 HELIX 12 AB3 SER A 732 GLY A 743 1 12 HELIX 13 AB4 PRO A 753 TRP A 764 1 12 HELIX 14 AB5 GLU A 767 ARG A 771 5 5 HELIX 15 AB6 SER A 773 GLN A 786 1 14 HELIX 16 AB7 PRO A 788 VAL A 794 1 7 SHEET 1 AA1 5 ILE A 510 GLY A 519 0 SHEET 2 AA1 5 GLY A 522 HIS A 530 -1 O VAL A 524 N LEU A 516 SHEET 3 AA1 5 LYS A 538 LEU A 546 -1 O MET A 539 N CYS A 529 SHEET 4 AA1 5 LEU A 586 GLU A 590 -1 O MET A 587 N LYS A 544 SHEET 5 AA1 5 PHE A 575 CYS A 579 -1 N GLY A 577 O VAL A 588 SHEET 1 AA2 2 CYS A 656 GLY A 659 0 SHEET 2 AA2 2 VAL A 663 ILE A 666 -1 O LYS A 665 N LEU A 657 SHEET 1 AA3 2 TYR A 681 VAL A 683 0 SHEET 2 AA3 2 THR A 687 LEU A 689 -1 O THR A 687 N VAL A 683 CISPEP 1 ARG A 583 PRO A 584 0 -2.27 SITE 1 AC1 11 GLY A 488 HIS A 489 ILE A 490 PHE A 521 SITE 2 AC1 11 LYS A 544 GLU A 560 LEU A 564 LEU A 567 SITE 3 AC1 11 HIS A 648 ASP A 668 GLY A 670 CRYST1 52.065 52.065 227.191 90.00 90.00 120.00 P 31 1 2 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019207 0.011089 0.000000 0.00000 SCALE2 0.000000 0.022178 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004402 0.00000